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Background: The United Nations Millennium Development Goals include targets for the health of children under
five years old. Poor health is linked to poverty and microfinance initiatives are economic interventions that may
improve health by breaking the cycle of poverty. However, there is a lack of reliable evidence to support this. In
addition, microfinance schemes may have adverse effects on health, for example due to increased indebtedness.
Rojiroti UK and the Centre for Promoting Sustainable Livelihood run an innovative microfinance scheme that
provides microcredit via women’s self-help groups (SHGs). This pilot study, conducted in rural Bihar (India), will
establish whether it is feasible to collect anthropometric and mortality data on children under five years old and
to conduct a limited cluster randomized trial of the Rojiroti intervention.
Methods/Design: We have designed a cluster randomized trial in which participating tolas (small communities
within villages) will be randomized to either receive early (SHGs and microfinance at baseline) or late intervention
(SHGs and microfinance after 18 months). Using predesigned questionnaires, demographic, and mortality data for
the last year and information about participating mothers and their children will be collected and the weight,
height, and mid upper arm circumference (MUAC) of children will be measured at baseline and at 18 months. The
late intervention group will establish SHGs and microfinance support at this point and data collection will be
repeated at 36 months.
The primary outcome measure will be the mean weight for height z-score of children under five years old in the
early and late intervention tolas at 18 months. Secondary outcome measures will be the mortality rate, mean
weight for age, height for age, prevalence of underweight, stunting, and wasting among children under five years
of age.
Discussion: Despite economic progress, marked inequalities in child health persist in India and Bihar is one of the
worst affected states. There is a need to evaluate programs that may alleviate poverty and improve health. This
study will help to inform the design of a definitive trial to determine if the Rojiroti scheme can improve the
nutrition and survival of children under five years of age in deprived rural communities.
Trial registration: Clinicaltrials.gov (study ID: NCT01845545). Registered on 24 April 2013.
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The direct link between poverty and poor health was
recognized in Europe in the nineteenth century [1]. More
recently the World Health Organization Commission on
Social Determinants of Health reported that the poor have
high levels of illness and premature mortality. In all coun-
tries, at all levels of income, health and wellbeing follow a
socioeconomic gradient, namely that, the lower the wealth
and social class, the worse the health [2]. The United
Nations Millennium Development Goals (MDGs) 1C and
4A [3] have focused the world’s attention on reducing
malnutrition and mortality in children under five years of
age.
Microfinance schemes provide small loans to poor
families to allow them to establish income-generating
activities that can potentially break the cycle of poverty.
Microfinance has been shown to reduce poverty, par-
ticularly among female participants, and is recognized
as a means to reduce overall village-level poverty in
participating communities [4]. There is some suggestion
that in addition to direct economic benefits, microfinance
initiatives reduce malnutrition in children [5] and have
large and positive effects on relative changes in children’s
health [6]. However, there is a lack of robust evidence to
support this [7] and as yet there are very few randomized
control trials (RCTs) in this field of research [8].
Need for a trial
Since its conception by Muhammud Yunus in 1978, in
Bangladesh, microfinance has developed at an astounding
pace. It has been credited with alleviating poverty, improv-
ing health, enhancing women’s empowerment, and bringing
about a myriad other social improvements [9]. However, as
early as the 1990s, the reliability of the evidence in support
of microfinance was being questioned [10]. This was soon
followed by the crash of the microcredit industry in Bolivia
and then in several other countries, culminating in a major
crisis in 2010 in Andhra Pradesh, India, where suicides
among rural borrowers who faced overwhelming debts
were coupled with vicious collection tactics from institu-
tional lenders [11]. Since then there has been an increasing
demand for an evidence based approach to evaluating such
programs. A systematic review of the impact of micro-
finance on the wellbeing of poor people concluded that
it could neither support nor deny the notion that
microfinance is pro-poor and pro-women [8]. There is
an urgent need for rigorous evaluation of microfinance
programs to ensure that such initiatives indeed bring
the social and health benefits that they promise and,
more importantly, do not harm the communities they
claim to support [12]. Randomized experiments pro-
vide a powerful method for evaluating the impact of
providing microfinance to previously unserved com-
munities [6]. Provision of microfinance is, however, acomplex intervention with several social and economic
interacting components. Whilst randomization may reduce
bias and confounding, a careful assessment using both
qualitative and quantitative methods would be required to
fully evaluate the true impact of microfinance [13].
While there is a great need to resolve whether microfi-
nance initiatives bring any health benefits to the partici-
pating communities, it is recognized that there are several
potential impediments to implementing a RCT protocol
and the acceptance of this approach in this setting [8].
Here we describe a pilot study to examine the feasibility of
conducting a cluster randomized trial in this rural Indian
community, and to make an initial assessment of the
Rojiroti microfinance scheme on the nutrition and sur-
vival of children under five years of age. The results
will inform the design of a larger, definitive trial of the
health effects of the Rojiroti scheme.
The Rojiroti model of microfinance
The reason cited for the disastrous consequences of con-
ventional microfinance initiatives, such as was seen in
Andhra Pradesh, is the adoption of these programs by large
commercial institutions primarily motivated by profit [14].
It has therefore been suggested that microfinance providers
need to return ownership to the borrowers [14]. The
United Kingdom Department for International Develop-
ment (DFID) supports the Rojiroti program which uses
an innovative approach for providing microfinance [15].
The program is run in areas of eastern Uttar Pradesh
and parts of Bihar in India by the Centre for Promoting
Sustainable Livelihood (CPSL) [16]. CPSL staff enter vil-
lages and identify volunteers from the village community
itself who go on to establish self-help groups (SGHs). The
members of the SHG are encouraged to save money in a
common pool to subsequently become eligible for a loan
from the SHG itself and from CPSL. The loans are made
for any purpose agreed upon within the SHG and are not
restricted to conventional income-generating activities, as
in conventional microfinance programs. Experience of
workers in the field suggests loans are initially used for
transport to government-subsidized shops and for hospital
visits. As SHGs mature, later loans might be used to pur-
chase livestock and improve housing. The approach offers
a process of supporting community development at a low
cost and aims to empower local villagers in managing
their own finances.
Objective
The initial objective is to determine if it is feasible and
acceptable to obtain informed consent and randomize
villages in Bihar to intervention or control arms of a trial,
to weigh and measure children and collect mortality data. If
feasible, we will also collect sufficient pilot data regarding
the effects of the intervention to allow us to subsequently
Table 1 Demographic and health statistics on Bihar
India Bihar
Area 3,287,263 km2 94,163 km2
Total population (2011 census) 1,210,193,422 103,804,637
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domized trial to evaluate the effect of the Rojiroti model
of microfinance on nutrition and survival of children
under five years of age.0-6-year-olds (2011 census) 158,789,287 18,582,229
Birth rate (per 1000 population in 2009) 22.5 28.5
Death rate (per 1000 population
in 2009)
7.3 7.0
Infant mortality rate (per 1000 live
births in 2009)
50 52
Sex ratio (females:males) 940:1000 916:1000
Literacy rate (percentage of population) 69 62
Statistics obtained from the Statistical Year Book 2012, India [17].Hypothesis
Our hypotheses are that it is feasible to conduct a cluster
randomized controlled trial of the Rojiroti microfinance
intervention in rural India. We also hypothesize that the
introduction of Rojiroti microfinance, through establishing
SHGs, will improve indicators of children’s nutrition,
measured on a continuous scale, such as weight for
height z-score (WHZ), weight for age z-score (WAZ),
height for age z-score (HAZ), and mean mid upper
arm circumference (MUAC) and that the Rojiroti microfi-
nance intervention will decrease the prevalence of under-
weight, stunting, wasting, and acute moderate and severe
malnutrition (as measured by MUAC) and mortality
among children under five years of age.Methods/Design
Study setting
The research study is being conducted in four administra-
tive blocks within the Patna district in Bihar: Dulhin Bazar,
Naubatpur, Masaurhi, and Bikram (Figure 1). In 2011,
Bihar had a population of 103,804,637, of which nearly
90% (92,075,028 people) lived in rural areas. Further
demographic data about Bihar are presented in Table 1Figure 1 Study site. The study is being conducted in the Patna
district in Bihar, India.[17]. The national poverty line used in India is based on
minimum essential expenditure and is much lower than
the World Bank figure – about $0.43/day [18]. Rojiroti
targets women who are poor by Indian standards and
hence, virtually all women who form Rojiroti SHGs will
be well below the World Bank extreme poverty line. We
have used the term 'very poor' to describe this group.
Study design
The study is a cluster RCT. The unit of randomization is
the tola; a small community within a village, comprised
of around 100 people. Participating tolas are all in the
same agro-economic zone. Past experience of CPSL
workers shows that when SHGs are set up in one tola,
news spreads by word of mouth to the neighboring vil-
lages, and other SHGs are formed in the surrounding
villages; to avoid such ‘viral’ spread of SHGs, the tolas in
intervention arm will be at least 15 km apart from the
tolas in the control arm. The process for requesting
informed consent is described below. After informed
consent is obtained, and prior to baseline data collection,
tolas in each pair will be randomly assigned to early or late
intervention.
Feasibility will be assessed in two stages. Initially, ten
pairs of tolas have been selected and randomized. Baseline
data will be collected from these tolas and at this point we
will review the acceptability of the data collection proce-
dures and tools and the quality of the data collected. If the
feasibility of the study is established, a further 10 pairs of
tolas will be similarly randomized to evaluate the effects
of the intervention on nutrition status and mortality in
children under five years of age.
The intervention
CPSL staff will identify village volunteers who will steer
the formation of women’s SHGs in the tolas randomized
to the early intervention group. Using the Rojiroti model
of microfinance [15], members of the SHG will each be
asked to save a small amount (Rs. 2.50 (£0.025)) every
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benefit from loans from two sources: initially from their
own pooled savings and, after three to six months of
running the SHG, also from CPSL. Applications for
loans will be made to the SHG, and the group can apply
to CPSL for the funds if it cannot provide the member
with the required amount. The loans can be taken for
any purpose approved by the group members. The annual
interest rate on a reducing balance is 18% for all loans,
providing interest payments are made and at least Rs 1
(£0.01) of the principal loan (the capital borrowed) is
repaid. If Rs 1 of the borrowed amount and the monthly
interest are not paid, an interest rate of 24% is charged per
annum. The participant seeking the loan has to specify the
loan tenure when receiving the loan; in the past CPSL
have recovered between 80 and 90% of the loans within
this specified time [15] and ultimately 99.3% of loans are
repaid. For this study, the total duration of external credit
will be recorded to analyze whether this affects health
outcomes.
The tolas randomized to the control arm will not
receive any intervention in the initial 18 months of the
study. After 18 months, CPSL staff will enter the control
tolas and provide support to establish SHGs and provide
microfinance in a manner similar to the process in the
tolas randomized to the intervention arm.
Outcome measures
The primary outcome measure will be the mean weight
for height z-score (WHZ) of children under five years of
age in the paired early and late intervention tolas at
18 months after the scheme has been implemented in
the early intervention tolas.
The secondary outcome measures will be mortality
rate, overall mortality, mean weight for age z-scores
(WAZ) and height for age z-scores (HAZ), the prevalence
of moderate to severe underweight (WAZ < −2 SD),
stunting (HAZ < −2 SD), and wasting (WHZ < −2 SD)
in children under five years of age, and the prevalence
of moderate to severe acute malnutrition (based on
MUAC between 12.5 and 11.5 cm and MUAC <11.5 cm,
respectively) in children between 6 and 60 months of age
[19] in the early versus late intervention tolas 18 months
from the start of the study. The same outcome measures
will be analyzed at 36 months to determine if the late
intervention tolas ‘catch up’.
Determining the primary outcome measure
At the initial stages of planning the study, the primary
outcome measures were mortality rate among children
under five years of age and the overall mortality in the
tola. However, on further literature review and discussion
with experts, the primary outcome was changed to the
mean WHZ of children under five years of age. Given theshort duration of the study and limited number of par-
ticipants, the effect of the intervention on mortality
rates may not be evident. WHZ is a marker of acute
malnutrition and wasting (WHZ < −2 SD) is associated
with a significantly increased risk of subsequent mor-
tality. Children with severe wasting (WHZ < −3 SD)
have a 9.4-fold higher chance of dying while those with
moderate wasting (WHZ −3 to −2 SD) have a 3.0-fold
higher chance of dying when compared with their non-
malnourished counterparts [20]. These figures are higher
compared to the odds ratios for mortality for HAZ and
similar to the odds ratios for WAZ. We chose WHZ as
the primary outcome measure as it is strongly associated
with mortality and may be affected by the intervention
within the short duration of the study period.
Qualitative measures
Qualitative data on the use of loans will be collected to
examine the purpose for requesting money. The analysis
will evaluate whether the purpose of loans changes in
the second 18-month period of the study. Experience of
CPSL workers suggests that loans are initially taken to
tide over emergencies. As SHGs mature, more loans are
taken for income-generating activities such as buying
livestock.
Sample size and power calculations
The data collected as part of this pilot study will be used
to inform sample size calculations for a future definitive
cluster RCT, using the methods described by Hayes and
Bennett [21]. Published estimates of nutrition in Bihar
date back to 2006 and suggest that 55% of under fives in
Bihar are underweight (61% of children from scheduled
castes) [22]. The pilot study will provide a current esti-
mate of the prevalence of mortality and malnutrition in
our study population.
The study will be initiated in 10 pairs of tolas to test
the feasibility of recruitment, randomization, and data
collection. When this is established, another 10 pairs of
tola will be recruited to complete the pilot phase of the
study. Based on local estimates of tola population and
number of children under five years of age in each tola,
20 pairs of tolas will be sufficient to allow a power calcu-
lation to determine the sample size required to detect a
statistically significant effect of Rojiroti microfinance on
the primary outcome measure.
Randomization and blinding
The 10 pairs of tolas for the feasibility phase were selected
by the CPSL staff and tola names converted into code
numbers which were provided to the research team based
at the University of Nottingham. The code numbers were
randomly assigned to either early or late intervention
by the researchers in Nottingham who were blind to
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back to the research team in Patna and the CPSL staff
who matched the randomly assigned allocations to the
tola name prior to baseline data collection. The re-
searchers in Nottingham who will perform data analysis
will remain blind to the tola allocation; however it is not
possible to blind the CPSL staff and participants as the
formation of SHGs and provision of microfinance
cannot be masked. A further 10 pairs of tolas will be
similarly randomized to complete the pilot phase of
the trial.
Data collection
Basic demographic information about each participating
tola will be collected at the beginning of the study
(Table 2). Information about each participating mother
and her child and/or children under five-years-old will
be collected using standard questionnaires. Data collected
will include immunization rates among the participat-
ing children and whether they have a ‘Road to Health
Card’ [23]. The Road to Health Card is a record of
immunization and growth of a child. It is given to the
mother when the child is born and is used to monitorTable 2 Data collected at baseline survey
Tola level information
(Collected from village
volunteer)
How many houses are there in this tola?
How many people live in this tola?
How many children under 5 years of age
live in this tola?
How many children were born in the last
1 year?
How many people have died in the last
1 year?
How many children under 5 years of age
have died in the last 1 year?
Information about mothers
(Collected from mother)
How old are you?
Can you read and write?
Have you ever been to school?
How many under children under 5 years
old do you have?
Do you or your family own any land?
Have you or your family had to sell any
assets due to emergencies such as money
required for medical treatment in the last
1 year?
Can you travel outside the village without
permission from your family?
Information about children
(Collected from mother)
Age
Gender
Has the child received any immunization?
Does the child have a Road to Health card?
Was the child born at home?child health until five years of age. Additional informa-
tion about the mothers such as ability to read and
write, years of schooling, freedom to travel without
permission, and whether they have needed to sell
assets in an emergency will also be collected. All ques-
tionnaires have been prepared in Hindi and will be
communicated to the participants by researchers who
can speak both Hindi and Magadhi, the local dialect of
Hindi spoken in the region.
The age, weight, height, and MUAC of each child under
five years of age will be recorded for all children in the
tola, irrespective of whether their mothers are in the SHG.
The measurement will be performed by CPSL field
workers. Two workers will work together to weigh and
measure each child and record the measurement that both
agree on. Standing height in children aged two years and
older will be measured with Seca 213 Portable Stadiometer
(Seca, Birmingham, UK) to the closest 1 mm. The length
of younger children will be measured using Seca 210
Measuring Mat (Seca, Birmingham, UK). Weight will be
measured with Libra Fitness Standing Scale (Edryl, Goa,
India); younger children will be weighed in hanging scales
(Venus CHS, Ace, Rajasthan, India) and smaller infants
and newborns on Docbel (Braun) Baby Scales (Popular,
Docbel Industries, New Delhi, India). All weights will be
recorded to the closest 100 g. MUAC will be measured
and recorded to the closest 1 mm using MUAC tapes
provided by the UNICEF Supply Division. CPSL staff
will determine and record the number of children under
five years of age who have not been measured (such as
children who are temporarily absent from the village
and those who are ill). This will be determined by asking
the village volunteers and the mothers if they know of
any children who are absent.
In addition, the village volunteer will estimate the total
population, the population under five years of age, and
the number of deaths in the last year (overall mortality
and deaths among children under five years of age) in
the tola. This information will collected using a standard
questionnaire.
After 18 months, all the participating children will be
reweighed and re-measured and data regarding overall
mortality and mortality among children under five
years of age during the study period in the tola will be
collected. The CPSL-supported SHGs will then be in-
troduced into the late intervention tolas. After 36 months
from the start of the study children’s weights, heights,
and MUACs will be recorded again, together with
mortality data, in all tolas. At 18 and 36 months, data
on deaths in each tola in the preceding 18 months
will be requested from the state government (Regis-
tration of Births and Deaths) and will be used to
check the validity of the mortality data obtained from
questionnaires.
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Tola information and individual participant information
will initially be recorded on paper questionnaires by
CPSL research staff and subsequently entered into elec-
tronic data sheets by the research team in Patna and
transferred to the University of Nottingham in secure
password-protected files. The original data sheets will
be scanned and electronic copies will be retained by the
research team in Nottingham while the original papers
will be retained by the team in Patna. All electronic and
paper records will be filed in numerical order and stored
on a secure server accessible to the research team.
The electronic records will be regularly backed up the
University of Nottingham.
Evaluating the accuracy and completeness of data collection
The electronic data sheets (Excel 2007; Microsoft Corpor-
ation, Redmond WA, USA) have data validation limits set
such that potentially spurious weights, heights, and
MUACs will be flagged up at the time of data entry and
can be rechecked against the paper records. Concordance
between paper records and data entered into the electronic
data sheets will be verified again by the researchers in
Nottingham. A 10% random sample of all paper records
will be checked against the electronic records. The
Emergency Nutrition Assessment Tool [24] will be used
to further check the data recorded in the electronic data
sheets for spurious age, height, and weight entries such
as a recorded height too small for the recorded age; any
entry flagged as suspicious will also be re-checked against
the paper records and any errors in data entry corrected.
If any spurious data remain, we will conduct a sensitivity
analysis for each of our outcome measures, excluding chil-
dren with a spurious age, height and/or weight record.
‘Viral’ spread of self-help groups
Previous experience of CPSL in the region indicates that
once SHGs begin in some tolas, information spreads by
word of mouth through relatives and women in nearby
tolas often set up their own SHGs (‘viral’ spread). In this
trial, paired early and late intervention tolas will be at
least 15 km apart in order to minimize viral SHGs being
set up in the late intervention tolas. To monitor viral
spread in this study, a local survey by CPSL staff will
determine how often nearby tolas set up SHGs. The
socioeconomic characteristics of group members in SHGs
which formed virally will be compared with those of
women in groups formed by CPSL. Where possible, con-
sent for the collection of health outcome data will be
taken and these data will be collected in the viral tolas
similar to the data collection in the randomized tolas.
CPSL staff will also record whether tolas assigned to the
late intervention arm proceed regardless and set up their
own SHGs during the first 18 months of the study.Statistical analysis
Type of analysis
In the feasibility and pilot study and any future trial,
intention-to-treat analysis will be used, that is, where a
tola has been randomized to receive microfinance early
or late, their data will be included irrespective of whether
the SHG and microfinance have run successfully or
whether the tolas in the late intervention group formed
SHGs through viral spread prior to their designated time.
Statistical tests
Using linear regression for continuous outcomes and
logistic regression for binary outcomes, we will compare
measurements from children in the early intervention
tolas and children in the late intervention tolas at
18 months. We will use a multilevel model to account
for the clustering of children within families within tolas,
and include baseline measurements of the outcome and
other confounders as model covariates. Tolas are being
recruited in pairs within agro-economic zones. All tolas
recruited thus far are in the same zone and all tolas in the
feasibility and pilot study will be in this same zone. Given
that tolas have not been matched on any other character-
istics, we will not account for the pairing of tolas in our
analysis.
Planned exploratory analyses
The feasibility and pilot phase will explore whether data
can be collected on maternal literacy and years of school-
ing women have received. If adequate data are available,
we will compare the effectiveness of the intervention ac-
cording to whether the mother was literate or illiterate
and whether she had received any years of schooling.
Ethical issues and the consent process
Ethics committee approval has been granted by the Univer-
sity of Nottingham’s Medical School Research Ethics
Committee (ethics reference number: J18102012) and by
the Patna Medical College Ethics Committee (document
dated 15 August 2013). Appropriate approval has also
been obtained from the Department of Health, Govern-
ment of Bihar, India (file number: −SHSB/NRC/2008/01/
Part III/2615).
Informed consent will be obtained by a novel approach,
approved by both ethics committees. We expect high
levels of illiteracy among the potential participants and
thus documented verbal consent may be more appropriate
in this setting. The CPSL fieldworker will give a verbal ex-
planation from an agreed script to the members of the
SHG. This script has been translated into Hindi and will
be explained by researchers who can speak both Hindi
and Magadhi; a video of the process is available at the
REACH project website [25]. In addition, information
sheets are provided, translated appropriately. The project
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press an interest in participating in the SHG. CPSL staff
will discuss the study, explain the reasons for conducting
such a study, what it would involve, and offer the option
of participation. One resident of each tola will be asked to
further consult with all the potential participants and give
written informed consent on behalf of all the residents.
Where there is no informed consent, the SHG will not
have health data collected and will not be randomized to
enter the study. The members of the SHGs will be
requested to give verbal consent on a collective basis,
using a show of hands to indicate willingness to partici-
pate. The consultation and collective consent will be video
recorded. Individual parental consent for participating
children will also be implied by the women volunteering
to bring the children to be weighed and measured. If the
women do not wish to participate in the study they will be
given the option to form the SHGs and receive microfi-
nance support outside of the trial.
Discussion
In India, despite rapid economic growth in the past few
decades and significant improvements in national aver-
age per capita gross domestic product (GDP), rates of
childhood malnutrition remain among the highest in
the world and progress has been slow [26]. This is
demonstrated by the 12 position decline from 1995 to
2010 in India’s ranking in the Child Development
Index (CDI), a global tool to assess the performance of
141 countries on child mortality, nutrition, and access
to primary education [27]. Bihar remains one of the
poorest states in India; in 2012 the per capita gross
domestic product (GDP) in Bihar was $343 compared
to the India average of $1,489 [28]. Nearly 90% of the
population lives in rural areas and has inadequate access
to health care and good quality education. In parallel with
poverty and economic and social deprivation, Bihar has
one of the worst records of children’s health and 23
districts from this state were ranked among the lowest
100 districts in the CDI and therefore included in the
recent Fighting Hunger and Malnutrition (HUNGaMA)
survey that focused on the nutritional status of children in
some of the worst-performing regions in India [29].
In a detailed analysis of poverty and inequality in
India, Rajan et al. [28] have suggested that to improve
public health, policymakers should focus on alleviating
poverty rather than simply raising average incomes,
highlighting the need for novel approaches to combat
poverty and malnutrition. The Rojiroti microfinance
program focuses on the most deprived and very poor
communities, with more than 90% of its participants
belonging to the scheduled castes. These are some of
the most socially disadvantaged groups and are known
to suffer from inadequate access to health care whichis disproportionately worse than that accessible to those of
higher castes and/or better socioeconomic status [30].
This study will assess the feasibility of conducting large
cluster randomized trials in some of the most deprived
and densely populated communities in rural areas in Bihar
[31] and will provide preliminary evidence to support or
refute the use of this novel microfinance initiative in im-
proving children’s health and nutrition.
Trial status
The trial is currently ongoing. The first 10 pairs of tolas
were randomized to early or late intervention and
baseline data collection was completed in late 2013 in
these communities. Further recruitment for the pilot
phase is ongoing.
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